Spanning five days, the 2019 Tri-Conference includes compelling talks, including case studies and joint partner presentations, will feature over 500 of your fellow industry and academic colleagues discussing themes of cancer research, big data, molecular diagnostics, precision medicine, rare diseases, data science, human microbiome, point-of-care diagnostics, infectious diseases, and so much more
Yole Développement will participate in the following:
“Microfluidic technologies are taking point-of-care testing to the next level”
On March 11th from 3:40PM to 4:10PM,
Sébastien Clerc, Technology & Market Analyst |Microfluidics & Medical Technologies | Life Sciences & Healthcare Division, Yole Développement
Abstract: The field of microfluidic-based point-of-care testing devices is enjoying nice dynamics and the pace at which new products are being commercialized is accelerating. Numerous fundraising operations, collaborations and mergers and acquisitions occur: the supply chain is structuring at a rapid pace as the market is booming ($3.5B in 2017, expected to reach $13.2B by 2023).
Historically, assays with more complex procedural steps were reserved for central labs to carry out, but over the last decade companies have leveraged microfluidic technologies to integrate all the required steps into single cartridges that can perform multiple tests in parallel.
In this talk, Yole’s analyst will share his view of the microfluidic market and technology, highlighting how such micro-structured devices enable new possibilities within the diagnostics industry in terms of automation, miniaturization, and integration of complex steps. Moreover, he will explain the remaining challenges that the players will face in the coming years along with the main market trends.
In addition, Yole Développement will be exhibiting on booth 908 with our experts on hand to answer questions and discuss your needs.